These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 9599703)

  • 21. In vitro systems for nephrotoxicity studies.
    Gandolfi AJ; Brendel K
    Toxicol In Vitro; 1990; 4(4-5):337-45. PubMed ID: 20702191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biotransformation and membrane transport in nephrotoxicity.
    Dekant W; Vamvakas S
    Crit Rev Toxicol; 1996 May; 26(3):309-34. PubMed ID: 8726165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro maintenance and functionality of primary renal tubules and their application in the study of relative renal toxicity of nephrotoxic drugs.
    Xu J; Patton D; Jackson SK; Purcell WM
    J Pharmacol Toxicol Methods; 2013; 68(2):269-274. PubMed ID: 23458725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphology of renal tubular damage from nephrotoxins.
    Pfaller W; Gstraunthaler G; Willinger CC
    Toxicol Lett; 1990 Sep; 53(1-2):39-43. PubMed ID: 2219185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicologic Pathology Forum Opinion Paper*: Recommendations for a Tiered Approach to Nonclinical Mechanistic Nephrotoxicity Evaluation.
    Ennulat D; Ringenberg M; Frazier KS
    Toxicol Pathol; 2018 Aug; 46(6):636-646. PubMed ID: 30049250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of an in vitro renal epithelial disease state model for xenobiotic toxicity testing.
    Crean D; Bellwon P; Aschauer L; Limonciel A; Moenks K; Hewitt P; Schmidt T; Herrgen K; Dekant W; Lukas A; Bois F; Wilmes A; Jennings P; Leonard MO
    Toxicol In Vitro; 2015 Dec; 30(1 Pt A):128-37. PubMed ID: 25536518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atractyloside nephrotoxicity: in vitro studies with suspensions of rat renal fragments and precision-cut cortical slices.
    Obatomi DK; Bach PH
    In Vitr Mol Toxicol; 2000; 13(1):25-36. PubMed ID: 10900405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephrotoxicity--what do we know and what don't we know?
    Skinner R
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):128-34. PubMed ID: 21285904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 3-D organoid kidney culture model engineered for high-throughput nephrotoxicity assays.
    Astashkina AI; Mann BK; Prestwich GD; Grainger DW
    Biomaterials; 2012 Jun; 33(18):4700-11. PubMed ID: 22444643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes.
    Ware BR; Berger DR; Khetani SR
    Toxicol Sci; 2015 Jun; 145(2):252-62. PubMed ID: 25716675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproduction and development.
    Spielmann H
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):571-6. PubMed ID: 9599704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephrotoxicity and Renal Pathophysiology: A Contemporary Perspective.
    Barnett LMA; Cummings BS
    Toxicol Sci; 2018 Aug; 164(2):379-390. PubMed ID: 29939355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Building predictive in vitro pulmonary toxicity assays using high-throughput imaging and artificial intelligence.
    Lee JJ; Miller JA; Basu S; Kee TV; Loo LH
    Arch Toxicol; 2018 Jun; 92(6):2055-2075. PubMed ID: 29705884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease.
    Pey R; Bach J; Schieren G; Gretz N; Hafner M
    In Vitro Cell Dev Biol Anim; 1999; 35(10):571-9. PubMed ID: 10614866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kidney-on-a-chip: untapped opportunities.
    Ashammakhi N; Wesseling-Perry K; Hasan A; Elkhammas E; Zhang YS
    Kidney Int; 2018 Dec; 94(6):1073-1086. PubMed ID: 30366681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative testing systems for evaluating noncarcinogenic, hematologic toxicity.
    Parchment RE
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):541-57. PubMed ID: 9599702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex-related differences in renal toxicodynamics in rodents.
    Trevisan A; Chiara F; Mongillo M; Quintieri L; Cristofori P
    Expert Opin Drug Metab Toxicol; 2012 Sep; 8(9):1173-88. PubMed ID: 22769852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The culture of renal epithelial cells: the physiological and pharmacological aspects].
    Berkhin EB
    Eksp Klin Farmakol; 1995; 58(4):69-75. PubMed ID: 7580759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection of drug-induced nephrotoxicity].
    Fillastre JP; Baud L; Baumelou A; Blanchard J; Bonvalet JP; Champey Y; Druet P; Glomot R; Imbs JL; Lagier G
    J Pharmacol; 1986; 17 Suppl 1():41-50. PubMed ID: 3747540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles.
    Sayes CM; Reed KL; Warheit DB
    Toxicol Sci; 2007 May; 97(1):163-80. PubMed ID: 17301066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.